Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.
Bruyn, G. A., Naredo, E., Iagnocco, A., Balint, P. V., Backhaus, M., Gandjbakhch, F., Gutierrez, M., Filer, A., Finzel, S., Ikeda, K., Kaeley, G. S., Magni Manzoni, S., Ohrndorf, S., Pineda, C., Richards, B., Roth, J., Schmidt, W. A., Terslev, L., D'Agostino, M. A., Aegerter, P., Aydin, S., Bong, D., Chary-Valckenaere, I., Collado, P., De Miguel, E., Dejaco, C., Epis, O., Freeston, J. E., Grassi, W., Hanova, P., Jousse-Joulin, S., Joshua, F., Koski, J., Loeuille, D., Moller, I., Ravagnani, V., Reginato, A., Sharp, V., Swen, N., Szkudlarek, M., Wakefield, R. J., Ziswiler, H. -., The OMERACT ultrasound working group 10 years on: Update at OMERACT 12, <<THE JOURNAL OF RHEUMATOLOGY>>, 2015; 42 (11): 2172-2176. [doi:10.3899/jrheum.141462] [http://hdl.handle.net/10807/169085]
The OMERACT ultrasound working group 10 years on: Update at OMERACT 12
D'Agostino, M. A.Conceptualization
;
2015
Abstract
Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
